Storebrand Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.4M | Sell |
|
|||||
|
2025
Q4 | $29.7M | Buy |
|
|||||
|
2025
Q3 | $32.8M | Buy |
|
|||||
|
2025
Q2 | $14.5M | Sell |
|
|||||
|
2025
Q1 | $12.2M | Sell |
|
|||||
|
2024
Q4 | $10.7M | Buy |
|
|||||
|
2024
Q3 | $6.38M | Buy |
|
|||||
|
2024
Q2 | $2.74M | Sell |
|
|||||
|
2024
Q1 | $2.77M | Sell |
|
|||||
|
2023
Q4 | $6.86M | Buy |
|
|||||
|
2023
Q3 | $6M | Sell |
|
|||||
|
2023
Q2 | $7.72M | Sell |
|
|||||
|
2023
Q1 | $8.34M | Sell |
|
|||||
|
2022
Q4 | $10.1M | Buy |
|
|||||
|
2022
Q3 | $8.25M | Sell |
|
|||||
|
2022
Q2 | $6.64M | Sell |
|
|||||
|
2022
Q1 | $7.49M | Sell |
|
|||||
|
2021
Q4 | $8.96M | Sell |
|
|||||
|
2021
Q3 | $10.1M | Sell |
|
|||||
|
2021
Q2 | $9.32M | Hold |
|
|||||
|
2021
Q1 | $7.76M | Buy |
|
|||||
|
2020
Q4 | $6.45M | Buy |
|
|||||
|
2020
Q3 | $5.46M | Buy |
|
|||||
|
2020
Q2 | $5.39M | Buy |
|
|||||
|
2020
Q1 | $2.99M | Buy |
|